Cardiac Chemiluminesence Immonoassay Creatine Kinase Isoenzyme Reagent
  • Cardiac Chemiluminesence Immonoassay Creatine Kinase Isoenzyme Reagent Manufacturers, Cardiac Chemiluminesence Immonoassay Creatine Kinase Isoenzyme Reagent Factory, Supply Cardiac Chemiluminesence Immonoassay Creatine Kinase Isoenzyme Reagent
  • Cardiac Chemiluminesence Immonoassay Creatine Kinase Isoenzyme Reagent Manufacturers, Cardiac Chemiluminesence Immonoassay Creatine Kinase Isoenzyme Reagent Factory, Supply Cardiac Chemiluminesence Immonoassay Creatine Kinase Isoenzyme Reagent

Cardiac Chemiluminesence Immonoassay Creatine Kinase Isoenzyme Reagent

Brand :Norman

Product origin :Nanjing

Delivery time :Two weeks after payment

Supply capacity :100,000 units/month

CK-MB Clinical Significance:
1. Began to rise after 3-8 hrs
2. Reach peak value after 8-24hrs
3. Return to normal value after 3 days
4. Early diagnosis of AMI and risk stratification .
5. Most valuable markers of non-ST-segment elevation MI
6. CK-MB mainly exists inmyocardium. Content of CK-MB in serum is sensitive and specific to myocardial damage.
7.CK-BB Mainly exists in brain, prostate,intestine,lung,bladder,uterus,placenta,and goiter.

Chemiluminesence Immonoassay Ck MB (Creatine Kinase Isoenzyme) Test Reagent:

Methodology: Chemiluminescence immunoassay


Product show:

Chemiluminesence-Immonoassay-Ck-MB-Creatine-Kinase-Isoenzyme-Test-Reagent.jpg                                                                                          

CK-MB:                                                                                                           

1. Registration No: Jiangsu food and drug administration 2014-2400618.
2. Important indicator for diagnosis of AMI.
3. Analyze  re-infarction and infarction size.

Clinical Significance:                                                                                       
1. Began to rise after 3-8 hrs
2. Reach peak value after 8-24hrs  
3. Return to normal value after 3 days
4. Early diagnosis of AMI and risk stratification .
5. Most valuable markers of non-ST-segment elevation MI
6. CK-MB  mainly exists inmyocardium. Content of CK-MB in serum is sensitive and specific to myocardial damage.
7.CK-BB Mainly exists in brain, prostate,intestine,lung,bladder,uterus,placenta,and goiter.
CK-MM  Mainly exists in skeletal muscle and myocardium.

Product advantage:                                                                                         
1. High sensitivity: 0.4ng/ml.
2. High accuracy : 99% result correlation with similar product of Siemens ADVIA Centaur.
3. Wide linear range: 0.4-300ng/ml.


Performance analysis                                                                                   

Correlation analysis between NORMAN CK-MB and Siemens ADVIACentaur CK-MB

Changes of myocardial markers after AMI attack

1. Myoglobin

2. Troponin(Large area infarction, e.g.STEMI

3. Troponin(Small area infarction  e.g.NSTEMI

4. CK-MB


Company profile:                                                                                             

Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing of automated chemiluminescence system. Founded in 2008, Norman biological has been upholding the idea that R&D shapes future ,and concentration determines success. Ever since the beginning,Norman has been focusing on developing and manufacturing  chemiluminescence and immunofluorescence  reagents.


6415.jpg



Agent Wanted: If you are interested in working with us, please feel free to contact. 

61.jpg

Why Us:                                                                                                                

1. Manufacturer and Exporter for nearly 10 years with self R&D Research Center;

2. Professional After-Sale service with On-site support worldwide; 
3. CE/ISO13485/SGS/RoHS Certifications!


OEM and ODM are available !


Get the latest price? We'll respond as soon as possible(within 12 hours)
close left right